Neurobiological Technologies Buy Hold or Sell Recommendation

NTIIDelisted Stock  USD 0.0001  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Neurobiological Technologies is 'Not Rated'. The recommendation algorithm takes into account all of Neurobiological Technologies' available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
In addition, we conduct extensive research on individual companies such as Neurobiological and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Neurobiological Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Execute Neurobiological Technologies Buy or Sell Advice

The Neurobiological recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Neurobiological Technologies. Macroaxis does not own or have any residual interests in Neurobiological Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Neurobiological Technologies' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Neurobiological TechnologiesBuy Neurobiological Technologies
Not Rated
For the selected time horizon Neurobiological Technologies has a Return On Equity of 1.0, Profit Margin of 0.74 %, Operating Margin of 0.77 %, Current Valuation of (26.24 M), Shares Outstanding of 27.02 M and Shares Owned By Institutions of 9.41 %
We provide investment recommendation to complement the last-minute expert consensus on Neurobiological Technologies. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Neurobiological Technologies is not overpriced, please verify all Neurobiological Technologies fundamentals, including its cash per share, as well as the relationship between the number of employees and current liabilities . As Neurobiological Technologies appears to be a penny stock we also strongly suggest to check its number of shares shorted numbers.

Neurobiological Technologies Trading Alerts and Improvement Suggestions

Neurobiological Technologies is not yet fully synchronised with the market data
Neurobiological Technologies has some characteristics of a very speculative penny stock
Neurobiological Technologies has a very high chance of going through financial distress in the upcoming years
Note: Neurobiological Technologies exotic insider transaction detected [view details]

Neurobiological Technologies Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Neurobiological . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Neurobiological Technologies Buy or Sell Advice

When is the right time to buy or sell Neurobiological Technologies? Buying financial instruments such as Neurobiological Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Neurobiological Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Compulsion Thematic Idea Now

Compulsion
Compulsion Theme
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Neurobiological Stock

If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bonds Directory
Find actively traded corporate debentures issued by US companies